Dr Reddys unveils OTC store-brand equivalent of Prevacid 24HR Capsules in US to treat heartburn

Dr Reddy’s OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, is an over-the-counter, Proton Pump Inhibitor (PPI) used to treat frequent heartburn occurring two or more days a week.

Hyderabad: Dr Reddy’s Laboratories Ltd. (Dr Reddys )today announced the launch of Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter (OTC) store-brand equivalent of Prevacid 24HR Capsules, in the United States market, as approved by the U.S. Food and Drug Administration (USFDA).

Dr Reddy’s OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, is an over-the-counter, Proton Pump Inhibitor (PPI) used to treat frequent heartburn occurring two or more days a week.

Commenting on the same, Milan Kalawadia, Senior Vice President and Head of US OTC and Specialty Rx Divisions Dr Reddy’s Laboratories said, "We are pleased to continue to expand our antacids and PPI portfolio for our customers. We look forward to collaborating with our customers to provide high-quality, affordable alternatives to consumers.”

The Prevacid 24HR brand and generic had U.S. sales of approximately $57 million MAT for the most recent twelve months ending in August 2019 according to IRI.

Read Also: Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

Dr Reddy’s OTC Lansoprazole Delayed-Release Capsules USP, 15 mg, are available in 14, 28 and 42 count sizes.

Prevacid is a registered trademark of Takeda Pharmaceuticals North America, Inc.

Read Also: Dr Reddys unveils a generic version of Zyban ER tablets in the US